The Effect of Coronavirus Disease-19 Pandemic Lockdown and the Overlapping Ramadan Fasting Period on Glucose Control in Insulin-Treated Patients With Diabetes: A Flash Glucose Monitoring Study.

COVID-19 Ramadan fasting flash glucose monitoring lockdown type 1 diabetes type 2 diabetes

Journal

Frontiers in nutrition
ISSN: 2296-861X
Titre abrégé: Front Nutr
Pays: Switzerland
ID NLM: 101642264

Informations de publication

Date de publication:
2022
Historique:
received: 27 12 2021
accepted: 11 02 2022
entrez: 18 4 2022
pubmed: 19 4 2022
medline: 19 4 2022
Statut: epublish

Résumé

A strict lockdown was enforced during coronavirus disease (COVID-19) pandemic in many countries including the UAE. Lockdown period overlapped with Ramadan which is accompanied by its own drastic changes in lifestyle that include meal timings. We report the impact of COVID-19 lockdown (between 22/3/2020 and 24/6/2020) on glucose control pre- and postlockdown and during Ramadan, in patients with type 1 diabetes (T1D) and type 2 diabetes (T2D) on insulin therapy. A number of twenty-four patients (19 men, 6 women) who were monitoring their glucose levels using flash glucose monitoring (FGM) and remotely connected to the diabetes clinic in Imperial College London Diabetes Centre (ICLDC), Abu Dhabi, UAE were included. Using the international consensus on the use of continuous glucose monitoring guidelines, analyses of data were performed on glucose management indicator (GMI), time in range (TIR), time in hyperglycemia, time in hypoglycemia, low blood glucose index (LBGI) and high blood glucose index (HBGI). Variables were calculated for each period: 30 days before lockdown 14/2/2020-14/3/2020, 30 days into lockdown and pre-Ramadan 20/3/2020-18/4/2020, and 30 days into lockdown and Ramadan 24/4/2020-23/5/2020, using cgmanalysis package in R-studio software. Mean average glucose (MAG) remained steady before and during lockdown, and no significant differences were observed in TIR, time in hypoglycemia, and LBGI between prelockdown and lockdown periods. However, there was a statistically significant difference in GMI and percentage of time in hyperglycemia (>10.0 mmol/L) between Ramadan and pre-Ramadan during the lockdown period in The lockdown period had no significant effects in the markers of glycemic control in the population studied. However, Ramadan fasting period embedded within this time was associated with several changes that include increase in GMI, HBGI, and glycemic variability similar to what has been reported in other Ramadan studies.

Sections du résumé

Background UNASSIGNED
A strict lockdown was enforced during coronavirus disease (COVID-19) pandemic in many countries including the UAE. Lockdown period overlapped with Ramadan which is accompanied by its own drastic changes in lifestyle that include meal timings.
Aims UNASSIGNED
We report the impact of COVID-19 lockdown (between 22/3/2020 and 24/6/2020) on glucose control pre- and postlockdown and during Ramadan, in patients with type 1 diabetes (T1D) and type 2 diabetes (T2D) on insulin therapy.
Methods UNASSIGNED
A number of twenty-four patients (19 men, 6 women) who were monitoring their glucose levels using flash glucose monitoring (FGM) and remotely connected to the diabetes clinic in Imperial College London Diabetes Centre (ICLDC), Abu Dhabi, UAE were included. Using the international consensus on the use of continuous glucose monitoring guidelines, analyses of data were performed on glucose management indicator (GMI), time in range (TIR), time in hyperglycemia, time in hypoglycemia, low blood glucose index (LBGI) and high blood glucose index (HBGI). Variables were calculated for each period: 30 days before lockdown 14/2/2020-14/3/2020, 30 days into lockdown and pre-Ramadan 20/3/2020-18/4/2020, and 30 days into lockdown and Ramadan 24/4/2020-23/5/2020, using cgmanalysis package in R-studio software.
Results UNASSIGNED
Mean average glucose (MAG) remained steady before and during lockdown, and no significant differences were observed in TIR, time in hypoglycemia, and LBGI between prelockdown and lockdown periods. However, there was a statistically significant difference in GMI and percentage of time in hyperglycemia (>10.0 mmol/L) between Ramadan and pre-Ramadan during the lockdown period in
Conclusion UNASSIGNED
The lockdown period had no significant effects in the markers of glycemic control in the population studied. However, Ramadan fasting period embedded within this time was associated with several changes that include increase in GMI, HBGI, and glycemic variability similar to what has been reported in other Ramadan studies.

Identifiants

pubmed: 35433783
doi: 10.3389/fnut.2022.843938
pmc: PMC9008837
doi:

Types de publication

Journal Article

Langues

eng

Pagination

843938

Informations de copyright

Copyright © 2022 Helal, Ashraf, Majeed and Lessan.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Diabetes Metab Syndr. 2020 Sep - Oct;14(5):1213-1216
pubmed: 32679527
Diabetes Res Clin Pract. 2020 Aug;166:108189
pubmed: 32360709
Foods. 2020 May 25;9(5):
pubmed: 32466106
Nutrients. 2020 May 28;12(6):
pubmed: 32481594
Diabetes Ther. 2020 Jun;11(6):1369-1379
pubmed: 32395187
Diabetes Res Clin Pract. 2020 Aug;166:108348
pubmed: 32711000
Obesity (Silver Spring). 2020 Aug;28(8):1382-1385
pubmed: 32352652
Diabetes Res Clin Pract. 2019 Apr;150:301-307
pubmed: 30768940
J Family Med Prim Care. 2020 Aug 04;9(8):3797-3806
pubmed: 33110770
Diabetes Res Clin Pract. 2020 Nov;169:108466
pubmed: 32971155
Diabetes Care. 2021 Mar;44(3):839-843
pubmed: 33361146
Diabetes Care. 2004 Oct;27(10):2306-11
pubmed: 15451892
Front Nutr. 2021 Mar 04;8:626432
pubmed: 33748175
Adv Ther. 2020 Apr;37(4):1550-1563
pubmed: 32144714
Nutr Metab Cardiovasc Dis. 2020 Aug 28;30(9):1423-1426
pubmed: 32600957
Indian J Endocrinol Metab. 2011 Oct;15(4):268-73
pubmed: 22028997
Diabetes Metab. 2015 Feb;41(1):28-36
pubmed: 25497966
Diabetes Res Clin Pract. 2019 Apr;150:282-287
pubmed: 30633934
Diabetes Care. 2020 Aug;43(8):e86-e87
pubmed: 32503838
Bull World Health Organ. 2001;79(4):373-4
pubmed: 11357217
Am J Health Behav. 2021 Jul 26;45(4):756-770
pubmed: 34340742
PLoS One. 2020 Jun 29;15(6):e0234443
pubmed: 32598395
Diabetes. 2013 May;62(5):1398-404
pubmed: 23613565
J Transl Med. 2020 Jun 8;18(1):229
pubmed: 32513197
Diabetes Care. 2017 Dec;40(12):1631-1640
pubmed: 29162583
Diabetes Res Clin Pract. 2021 Feb;172:108626
pubmed: 33321160
Food Control. 2021 Jul;125:107934
pubmed: 33564215
Diabetes Technol Ther. 2020 May 12;:
pubmed: 32396400
PLoS One. 2019 Oct 11;14(10):e0216851
pubmed: 31603912
Nutrients. 2020 Jun 17;12(6):
pubmed: 32560550
Diabetes Care. 2019 Aug;42(8):1593-1603
pubmed: 31177185

Auteurs

Radwa Helal (R)

Imperial College London Diabetes Centre, Abu Dhabi, United Arab Emirates.

Tanveer Ashraf (T)

Imperial College London Diabetes Centre, Abu Dhabi, United Arab Emirates.

Maria Majeed (M)

Imperial College London Diabetes Centre, Abu Dhabi, United Arab Emirates.

Nader Lessan (N)

Imperial College London Diabetes Centre, Abu Dhabi, United Arab Emirates.

Classifications MeSH